Carvykti Approved for Relapsed/Refractory Multiple Myeloma

Press/Media

Period	2 Mar 2022

Media coverage

Title	Carvykti Approved for Relapsed/Refractory Multiple Myeloma
Media name/outlet	Cancer Therapy Advisor
Country/Territory	United States
Date	2/03/22
URL	https://www.cancertherapyadvisor.com/home/cancer-topics/multiple-myeloma/carvykti-approved-for-relapsed-refractory-multiple-myeloma/
Persons	Sundar Jagannath